Radical nephrectomy and vena caval thrombectomy with the use of cardiopulmonary bypass and hypothermic circulatory arrest: Experience at a large tertiary institution

Abstract

Objective:

This study aimed to review the experience at a large regional tertiary centre of open radical nephrectomy (RN) with vena caval thrombectomy with cardiopulmonary bypass (CPB) and hypothermic circulatory arrest (HCA) for the management of renal masses.

Method:

Data on patients with renal masses who had undergone RN and vena caval thrombectomy with CPB and HCA had been prospectively collected at two centres over a 19-year period (2000–2019). Twenty-three consecutive patients were identified and retrospectively analysed for operative and tumour characteristics and for postoperative outcome. Kaplan–Meier survival analysis was performed to compare patient outcomes based on tumour characteristics.

Results:

Median operating time was 358 minutes (interquartile range (IQR)=94 minutes), median bypass time was 117 minutes (IQR=28.5 minutes) and median circulation arrest time was 25 minutes (IQR=18.5 minutes). The median hospital length of stay was 11 days (IQR=5.3 days). Total complication rate was 52% (n=12), consisting of four minor and eight major complications (Clavien–Dindo score >IIIa), including one intraoperative death. The overall five-year survival rate was 73% (11/15), with a median follow-up time of 53.1 months. Eleven (48%) patients were surgically cured, with a median follow-up time of 60.1 months (IQR=71.8 months). Disease recurrence was seen in eight (35%) patients, of whom four died. Patients who died survived for a median of 46.5 months. Median survival after the diagnosis of metastatic disease was seven months.

Conclusions:

We report the largest Australian cohort of RN with vena caval thrombectomy with CPB and HCA. We demonstrate outcomes comparable to major overseas centres, with an overall five-year survival rate of 73%. This suggests that even patients with extensive venal caval thrombus from renal masses can experience long-term survival benefit from RN and venal caval thrombectomy.

Level of evidence:

Level 3.

Keywords

Nephrectomy cardiopulmonary bypass deep hypothermic cardiac arrest venous tumour thrombus oncology renal cell carcinoma

Get full access to this article

View all access options for this article.

References

Australian Institute of Health and Welfare and Australasian Association of Cancer Registries. Cancer survival in Australia, 2001. Part 1: National summary statistics. AIHW cat. no. CAN 13. Cancer Series no. 18. Canberra: Australian Institute of Health and Welfare, 2001.

Lardas

Stewart

Scrimgeour

, et al. Systematic review of surgical management of nonmetastatic renal cell carcinoma with vena caval thrombus. Eur Urol 2016; 70: 265–280.

Bazzi

Sjoberg

Feuerstein

, et al. Long-term survival rates after resection for locally advanced kidney cancer: Memorial Sloan Kettering Cancer Center 1989 to 2012 experience. J Urol 2015; 193: 1911–1916.

Blute

Leibovich

Lohse

, et al. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int 2004; 94: 33–41.

Cao

Liang

, et al. Long-term survival and prognostic factors for locally advanced renal cell carcinoma with renal vein tumor thrombus. BMC Cancer 2019; 19: 144.

Ljungberg

Albiges

Abu-Ghanem

, et al. European Association of Urology guidelines on renal cell carcinoma: the 2019 update. Eur Urol 2019; 75: 799–810.

Gaudino

Lau

Cammertoni

, et al. Surgical treatment of renal cell carcinoma with cavoatrial involvement: a systematic review of the literature. Ann Thorac Surg 2016; 101: 1213–1221.

Kaag

Toyen

Russo

, et al. Radical nephrectomy with vena caval thrombectomy: a contemporary experience. BJU Int 2011; 107: 1386–1393.

Neves

Zincke

Surgical treatment of renal cancer with vena cava extension. Br J Urol 1987; 59: 390–395.

10.

Quencer

Friedman

Sheth

, et al. Tumor thrombus: incidence, imaging, prognosis and treatment. Cardiovasc Diagn Ther 2017; 7: S165–S177.

11.

Clavien

Barkun

De Oliveira

, et al. The Clavien–Dindo classification of surgical complications: five-year experience. Ann Surg 2009; 250: 187–196.

12.

Zhu

Chen

, et al. The role of deep hypothermic circulatory arrest in surgery for renal or adrenal tumor with vena cava thrombus: a single-institution experience. J Cardiothorac Surg 2018; 13: 85.

13.

Amin

Greene

Edge

, et al. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin 2017; 67: 93–99.

14.

Bakshi

Vishal

Kalia

, et al. Aggressive renal angiomyolipoma extending into the renal vein and inferior vena cava – an uncommon entity. Br J Radiol 2011; 84: e166–e168.

15.

Melo Abreu

Cunha

. Renal angiomyolipoma with renal vein thrombosis: an incidental finding. BJR Case Rep 2016; 2: 20150218.

16.

Reese

Whitson

Meng

MV.

Natural history of untreated renal cell carcinoma with venous tumor thrombus. Urol Oncol 2013; 31: 1305–1309.

17.

Campi

Tellini

Sessa

, et al. Techniques and outcomes of minimally-invasive surgery for nonmetastatic renal cell carcinoma with inferior vena cava thrombosis: a systematic review of the literature. Minerva Urol Nefrol 2019; 71: 339–358.

18.

Tilki

, et al. Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus. Eur Urol 2014; 66: 577–583.

19.

Mickisch

Garin

Van Poppel

, et al. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet 2001; 358: 966–970.

20.

Westesson

Klink

Rabets

, et al. Surgical outcomes after cytoreductive nephrectomy with inferior vena cava thrombectomy. Urology 2014; 84: 1414–1419.

21.

Okamura

Terakawa

Sakamoto

, et al. Presurgical pazopanib improves surgical outcomes for renal cell carcinoma with high-level IVC tumor thrombosis. In Vivo 2019; 33: 2013–2019.

22.

Rigaud

Hetet

J-F

Braud

, et al. Surgical care, morbidity, mortality and follow-up after nephrectomy for renal cancer with extension of tumor thrombus into the inferior vena cava: retrospective study since 1990s. Eur Urol 2006; 50: 302–310.

23.

Abaza

Initial series of robotic radical nephrectomy with vena caval tumor thrombectomy. Eur Urol 2011; 59: 652–656.

24.

Gill

Metcalfe

Abreu

, et al. Robotic level III inferior vena cava tumor thrombectomy: initial series. J Urol 2015; 194: 929–938.

25.

Hoang

Vaporcyian

Matin

SF.

Laparoscopy-assisted radical nephrectomy with inferior vena caval thrombectomy for level II to III tumor thrombus: a single-institution experience and review of the literature. J Endourol 2010; 24: 1005–1012.

26.

Abaza

Technical considerations in robotic nephrectomy with vena caval tumor thrombectomy. Indian J Urol 2014; 30: 283–286.

27.

Abaza

Eun

Gallucci

, et al. Robotic surgery for renal cell carcinoma with vena caval tumor thrombus. Eur Urol Focus 2016; 2: 601–607.